Hanne Verswyvel

Chapter 5 │ Page 190 17. F. Alonso, S. Domingos-Pereira, L. Le Gal, L. Derré, P. Meda, P. Jichlinski, D. NardelliHaefliger, J. A. Haefliger, Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion, Oncotarget 7 (2016) 1401514028. 18. G. M. Yusubalieva, V. P. Baklaushev, O. I. Gurina, Y. A. Zorkina, I. L. Gubskii, G. L. Kobyakov, A. V. Golanov, S. A. Goryainov, G. E. Gorlachev, A. N. Konovalov, A. A. Potapov, V. P. Chekhonin, Treatment of poorly di erentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy, Bull. Exp. Biol. Med. 157 (2014) 510-515. 19. G. H. Kalimi and S. M. Sirsat, Phorbol ester tumor promoter a ects the mouse epidermal gap junctions, Cancer Lett. 22 (1984) 343-350. 20. M. L. Acosta, M. N. M. Nor, C. X. Guo, O. O. Mugisho, F. P. Coutinho, I. D. Rupenthal, C. R. Green, Connexin therapeutics: blocking connexin hemichannel pores is distinct from blocking pannexin channels or gap junctions, Neural Regen. Res. 16 (2021) 482488. 21. Y. P Subedi, G. A. Altenberg, C-W. T. Chang, Advances in the development of connexin hemichannel inhibitors selective toward Cx43, Future Med. Chem. 13 (2021) 379-392. 22. M. Bol, C. V. Geyt, S. Baert, E. Decrock, N. Wang, M. De Bock, A. K. Gadicherla, C. Randon, W. H. Evans, H. Beele, R. Cornelissen, L. Leybaert, Inhibiting connexin channels protects against cryopreservation-induced cell death in human blood vessels, Eur. J. Vasc. Endovasc. Surg. 45 (2013) 382-390. 23. M. Jaraíz-Rodríguez, M. D. Tabernero, M. González-Tablas, A. Otero, A. Orfao, J. M. Medina, A. Tabernero, A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK, Stem Cell Rep. 9 (2017) 451-463. 24. G. M. Yusubalieva, V. P. Baklaushev, O. I. Gurina, M. V. Gulyaev, Y. A. Pirogo, V. P. Chekhonin, Antitumor e ects of monoclonal antibodies to connexin 43 extracellular fragment in induced low-di erentiated glioma, Bull. Exp. Biol. Med. 153 (2012) 163169. 25. V. De Meulenaere, E. Bonte, J. Verhoeven, J-P. K. Okito, L. Pieters, A. Vral, O. De Wever, L. Leybaert, I. Goethals, C. Vanhove, B. Descamps, K. Deblaere, Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A preclinical F98 glioblastoma rat model study, PLoS ONE 14 (2019) e0224130. 26. Q. Chen, A. Boire, X. Jin, M. Valiente, E. E. Er, A. Lopez-Soto, L. S. Jacob, R. Patwa, H. Shah, K. Xu, J. R. Cross, J. Massague, Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer, Nature 533 (2016) 493-498. 27. Y-P. Zhao, B. Liu, Q. Wang, D-D. Yuan, Y. Yang, X-T. Hong, X-D. Wang, L. Tao, Propofol Depresses the Cytotoxicity of X-ray Irradiation Through Inhibition of Gap Junctions, Anest. Anal. 112 (2011) 1088-1095. 28. S. F. Murphy, R. T. Varghese, S. Lamouille, S. Guo, K. J. Pridham, P. Kanabur, A. M. Osimani, S. Sharma, J. Jourdan, C. M. Rodgers, G. R. Simonds, R. G. Gourdie, Z. Sheng, Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide, J. Cancer Res. 76 (2016) 139-149. 29. D. B. Cowan, M. Jones, L. M. Garcia, S. Noria, P. J. del Nido, F. X. McGowan Jr, Hypoxia and Stretch Regulate Intercellular Communication in Vascular Smooth Muscle Cells

RkJQdWJsaXNoZXIy MTk4NDMw